- Home
- NURO vs APTO Comparison
NURO vs APTO Comparison
Compare NURO & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- APTO
- Stock Information
- Founded
- NURO 1996
- APTO 1986
- Country
- NURO United States
- APTO Canada
- Employees
- NURO N/A
- APTO N/A
- Industry
- NURO Medical/Dental Instruments
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NURO Health Care
- APTO Health Care
- Exchange
- NURO Nasdaq
- APTO Nasdaq
- Market Cap
- NURO 7.6M
- APTO 7.2M
- IPO Year
- NURO N/A
- APTO N/A
- Fundamental
- Price
- NURO $3.93
- APTO $0.37
- Analyst Decision
- NURO
- APTO Strong Buy
- Analyst Count
- NURO 0
- APTO 4
- Target Price
- NURO N/A
- APTO $9.00
- AVG Volume (30 Days)
- NURO 21.2K
- APTO 73.2K
- Earning Date
- NURO 11-05-2024
- APTO 11-08-2024
- Dividend Yield
- NURO N/A
- APTO N/A
- EPS Growth
- NURO N/A
- APTO N/A
- EPS
- NURO N/A
- APTO N/A
- Revenue
- NURO $3,767,764.00
- APTO N/A
- Revenue This Year
- NURO N/A
- APTO N/A
- Revenue Next Year
- NURO N/A
- APTO N/A
- P/E Ratio
- NURO N/A
- APTO N/A
- Revenue Growth
- NURO N/A
- APTO N/A
- 52 Week Low
- NURO $2.66
- APTO $0.33
- 52 Week High
- NURO $4.73
- APTO $2.91
- Technical
- Relative Strength Index (RSI)
- NURO 45.39
- APTO 49.17
- Support Level
- NURO $3.56
- APTO $0.37
- Resistance Level
- NURO $3.80
- APTO $0.41
- Average True Range (ATR)
- NURO 0.30
- APTO 0.02
- MACD
- NURO -0.03
- APTO 0.00
- Stochastic Oscillator
- NURO 37.75
- APTO 42.00
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.